Published research showed that FBXO39 cancer/testis antigen was considered a promising biomarker for the prognosis of cervical squamous cell carcinoma [11], breast [12], colon [13], and glioma cancer [14]. This evidence concerns the gene FBXO39 and cervical squamous cell carcinoma.